PASEF News and Research

RSS
Parallel accumulation – serial fragmentation (PASEF) is a spectroscopic technique used during liquid chromatography-mass spectrometry (LC-MS) based proteomics to improve sequencing speed and sensitivity.
When cancer research turns to the immune system – the critical role of peptides and immunopeptidomics

When cancer research turns to the immune system – the critical role of peptides and immunopeptidomics

New Bruker-Biognosys collaboration aims to deliver advanced proteomics CRO services

New Bruker-Biognosys collaboration aims to deliver advanced proteomics CRO services

Evosep One enables robust, high throughput, single cell proteomics

Evosep One enables robust, high throughput, single cell proteomics

Acquiring real-time, accurate and reproducible 4D bioinformatics data with PaSER

Acquiring real-time, accurate and reproducible 4D bioinformatics data with PaSER

Discover, Visualize and Identify Biomarkers

Discover, Visualize and Identify Biomarkers

Bruker announces new results in deep, unbiased plasma proteomics, PaSER 1.1 software and new cross-linking consumables at US HUPO 2021

Bruker announces new results in deep, unbiased plasma proteomics, PaSER 1.1 software and new cross-linking consumables at US HUPO 2021

New Nature Communications publication by Mann & Theis Groups harnesses the benefits of large-scale peptide collisional cross section (CCS) measurements and deep learning for 4D-proteomics

New Nature Communications publication by Mann & Theis Groups harnesses the benefits of large-scale peptide collisional cross section (CCS) measurements and deep learning for 4D-proteomics

Bruker and Evosep announce major progress in unbiased, quantitative true single-cell proteomics

Bruker and Evosep announce major progress in unbiased, quantitative true single-cell proteomics

Exploring the Relationship Between Mass Spectrometry and Informatics

Exploring the Relationship Between Mass Spectrometry and Informatics

Bruker introduces breakthrough MALDI-2 source on timsTOF fleX, and further innovations in CCS-enabled 4D proteomics on timsTOF

Bruker introduces breakthrough MALDI-2 source on timsTOF fleX, and further innovations in CCS-enabled 4D proteomics on timsTOF

Combining Improved Ion Usage Efficiency with Data Independent Acquisition to Quantify Proteomes

Combining Improved Ion Usage Efficiency with Data Independent Acquisition to Quantify Proteomes

Investigating Human Disease with Mass Spectrometry-based Proteomics

Investigating Human Disease with Mass Spectrometry-based Proteomics

Applying a Proteomics-based Approach to the Clinic

Applying a Proteomics-based Approach to the Clinic

Monitoring the Human Proteome using diaPASEF

Monitoring the Human Proteome using diaPASEF

New software will accelerate data-independent acquisition (DIA) proteomics experiments

New software will accelerate data-independent acquisition (DIA) proteomics experiments

Bruker announces novel phenomics solutions at Metabolomics 2019

Bruker announces novel phenomics solutions at Metabolomics 2019

Bruker launches timsTOF fleX with ESI/MALDI capability for SpatialOMx at ASMS 2019

Bruker launches timsTOF fleX with ESI/MALDI capability for SpatialOMx at ASMS 2019

Bruker’s timsTOF Pro mass spectrometer receives EuPA technology award at Proteomic Forum 2019

Bruker’s timsTOF Pro mass spectrometer receives EuPA technology award at Proteomic Forum 2019

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.